Key Points:
- A major Bloomberg study found that 66% of companies cut jobs over the past 12 months due to AI deployment.
- Despite short-term layoffs, 60% of corporate executives expect overall headcounts to grow by 4% over the next three years.
- The software and IT services sector faces the highest risk, with 50% of firms planning to reduce their workforce.
- Automating workflows is cutting pharmaceutical drug development costs by 16% and reducing industrial cycle times by 30%.
Artificial intelligence is quickly rewriting the corporate playbook, driving significant job cuts and forcing a massive restructuring of the global workforce. An inaugural survey from Bloomberg Intelligence revealed that companies across nine major industries are rapidly deploying AI to protect their market share. While the technology promises massive productivity gains, it is also forcing corporate leaders to make tough decisions about headcount and resource reallocation.
The most striking finding of the survey centers on near-term job losses. The research shows that 66% of companies executed job cuts over the past 12 months as a direct result of deploying artificial intelligence tools. However, technology analysts note that these cuts reflect a strategic reallocation of corporate resources rather than a simple net reduction in employees. Companies are letting go of workers in legacy roles and hiring specialized talent to run their new automated systems.
Surprisingly, corporate executives still hold a highly optimistic view of long-term employment. More than 60% of surveyed business leaders expect their total headcount actually to increase over the next three years. The survey projects an average headcount gain of 4% across these companies on a three-year view. This dual trend suggests that while AI causes severe disruption and job losses in the short term, it will eventually generate new roles as businesses scale up their automated operations.
Virtually every major industry now recognizes the disruptive potential of this technology. All nine surveyed sectors rated the risk of AI disruption as either high or very high. Interestingly, most executives see a much bigger threat to their broader industry than to their own specific organizations. The data showed that 80% of business leaders fear a major industry-level disruption, while only 69% worry about their own companies falling behind.
This fear of being left behind is driving massive corporate investments. The study found that 36% of companies make artificial intelligence their single top priority, while another 47% list it as a top-three priority. Executives are expanding their tech budgets at a rapid pace, with companies planning an average 14% increase in near-term AI spending during 2026. Rather than chasing vague future growth, 36% of these firms are investing to protect their existing market positions.
The software and IT services sectors are the earliest to embrace these tools, but they also face the steepest workforce cuts. The survey revealed that 66% of tech executives rate the disruption risk to their industry as very high, compared to just 38% across other sectors. Half of these software firms expect to reduce their total workforce over the next three years. They anticipate that artificial intelligence will write more than 50% of all new computer code within that timeframe, drastically reducing the need for junior programmers.
The media industry faces a similar struggle, with 52% of executives expecting their headcounts to decline over the next three years. They anticipate that generative technology will significantly reduce the costs of content production, distribution, and monetization. Meanwhile, the retail and consumer goods sector is taking a different path. Rather than reducing staff, 92% of retail companies plan to increase their tech spending to focus on personalization and improve the customer experience, expecting a mid-single-digit sales boost.
The healthcare and pharmaceutical industries are also experiencing a major shift. Drug developers plan to shift between 10% and 30% of their preclinical research work to advanced computer models. This automation is expected to decrease overall drug development costs by an average of 16% and shave 6 to 18 months off the time-to-market for novel medicines. Hospitals also anticipate a major productivity boost, with 56% of administrators expecting AI to revolutionize clinical decisions, diagnostics, and billing.
In the industrial sector, executives expect artificial intelligence to reduce sales cyclicality and boost profit margins. Around 80% of industrial leaders expect these smart tools to drive a meaningful increase in recurring revenues. They also anticipate a 30% reduction in product development cycle times as automated systems handle heavy engineering and design tasks, allowing factories to bring new products to market much faster.
Anurag Rana, a senior technology analyst at Bloomberg Intelligence, explained that companies are using the technology as a golden opportunity to improve productivity rather than simply cut costs. He noted that the single most important metric for future corporate success will likely be sales per employee. As the corporate world continues to adapt, the real winners will be the businesses that can successfully embed artificial intelligence across the majority of their daily operations.
